组4 4例用门冬氨酸钾镁和五酯胶囊。
门冬氨酸钾镁；
目的 ：探讨门冬氨酸钾镁在急性心肌梗死治疗中的应用价值。
Objective:To observe the benefits of potassium-magnesium aspartate in acute myocardial infarction .
门冬氨酸钾镁可使37.50%的患者心功能改善，但左室射血分数无明显变化。
Potassium magnesium aspartate could improve heart function in 37.50%patients only but with no effect on LVEF.
目的探讨镁离子制剂（门冬氨酸钾镁）对脑弥漫性轴索损伤（DAI）的治疗作用。
Objective To investigate the result of potassium magnesium aspartate for treatment of diffuse axonal injury (DAI).
结论：对于未行溶栓治疗高龄急性心肌梗死病人早期应用门冬氨酸钾镁治疗可能改善预后。
Conclusion: Early application of potassium magnesium aspartate can improve the prognosis of aged patients of acute myocardial infarction without thrombolytic therapy.
治疗组在西医基础治疗上每日煎服自拟的凉血活血退黄汤，对照组采用门冬氨酸钾镁注射液。
Treatment group decoct soup daily on the basic treatment of Western medicine, the control group use potassium-magnesium aspartate injection.
方法：应用随机交叉对比的方法，对16例慢性充血性心力衰竭患者进行参麦注射液和门冬氨酸钾镁治疗比较。
Methods: Effect of 16 cases treated with SMI or potassium magnesium aspartate was observed by randomized cross-over method and compared.
方法：应用随机交叉对比的方法，对16例慢性充血性心力衰竭患者进行参麦注射液和门冬氨酸钾镁治疗比较。
Methods: Effect of 16 cases treated with SMI or potassium magnesium aspartate was observed by randomized cross-over method and compared.
应用推荐